Pharmaceutical Research Unit

Established in 1993, as the first CRO in Jordan, PRU has been providing biopharmaceutical services for over two decades to more than a hundred pharmaceuticals throughout Europe, Asia, Africa, and the USA. At Pharmaceutical Research Unit (PRU), we aim to reformulate the future as we work hand in hand with our partners to help them develop effective, quality-driven products by providing full clinical research services, while preserving a safe environment. Our commitment in delivering precise results in our research in a timely and cost-effective manner is the primary catalyst in transforming scientific discoveries into new treatments. Services: • Medical and Regulatory writing • Clinical Trials set up • Bioanalysis • Data management and Statistical analysis • Project Management Accreditation and Inspection Milestones: • Jordan Food and Drug Administration (JFDA) • United States Food and Drug Administration (USFDA) • Spanish Agency of Medicines and Medical Devices (AEMPS) • Belgium Federal Agency for Medicines and Health Products (AFMPS) • Turkish Ministry of Health (MOH) • Gulf Cooperation Council (GCC) • Malaysian National Pharmaceutical Regulatory Agency (NPRA) Experience: Our expertise lies in a variety of pharmaceutical areas including: Oncology, Hormones, Controlled medications, Biosimilars, Transdermal patches, Immuno-suppressants, Endogenous compounds and Female products. Clinical Study Time Frame: • 1 week - Protocol preparation and approval by Sponsor • 10 Days - Protocol approval by the JFDA • 10- 20 Days - Bioanalysis • 8 days - Final study report preparation following the release of initial results